Comparative studies on the human serum albumin binding of the clinically approved EGFR inhibitors gefitinib, erlotinib, afatinib, osimertinib and the investigational inhibitor KP2187
- Author(s)
- Orsolya Domotor, Karla Pelivan, Attila Borics, Bernhard K. Keppler, Christian R. Kowol, Eva A. Enyedy
- Organisation(s)
- Department of Inorganic Chemistry
- External organisation(s)
- University of Szeged, Hungarian Academy of Sciences
- Journal
- Journal of Pharmaceutical and Biomedical Analysis
- Volume
- 154
- Pages
- 321-331
- No. of pages
- 11
- ISSN
- 0731-7085
- DOI
- https://doi.org/10.1016/j.jpba.2018.03.011
- Publication date
- 05-2018
- Peer reviewed
- Yes
- Austrian Fields of Science 2012
- 301904 Cancer research, 301207 Pharmaceutical chemistry
- Keywords
- ASJC Scopus subject areas
- Drug Discovery, Analytical Chemistry, Spectroscopy, Clinical Biochemistry, Pharmaceutical Science
- Sustainable Development Goals
- SDG 3 - Good Health and Well-being
- Portal url
- https://ucrisportal.univie.ac.at/en/publications/aa347a8b-f817-4951-8a81-19e2df56c669